Get the Stockscreener App
15.83
0.13%
0.02
After Hours:
15.85
0.02
+0.13%
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Stock (BIS) Forecast
The Proshares Ultrashort Nasdaq Biotechnology 2 X Shares (BIS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.6708, representing a -83.13% decrease from the current price of $15.83. The highest analyst price target is $5.3337, and the lowest is $0.00793.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BIS Price Target
Average 15.02
(-5.09% Downside)
Is Proshares Ultrashort Nasdaq Biotechnology 2 X Shares (BIS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.10 | Neutral |
| STOCH(9,6) | 33.30 | Neutral |
| STOCHRSI(14) | 27.96 | Neutral |
| MACD(12,26) | 0.2625 | Sell |
| ADX(14) | 17.68 | Neutral |
| William %R | -55.75 | Neutral |
| CCI(14) | -38.53 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
16.83
Sell
|
16.28
Sell
|
| MA20 |
15.99
Sell
|
16.11
Sell
|
| MA50 |
15.56
Buy
|
15.73
Buy
|
| MA100 |
15.25
Buy
|
15.81
Buy
|
| MA200 |
16.58
Sell
|
16.78
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, BIS could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 7 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on BIS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 48.1 indicates that BIS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 33.3 indicates that BIS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 27.96 indicates that BIS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.68 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -38.53 indicates that BIS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BIS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Proshares Ultrashort Nasdaq Biotechnology 2 X Shares financial reports and earnings history, Proshares Ultrashort Nasdaq Biotechnology 2 X Shares (BIS) stock could reach $33.09 by 2030, $50.36 by 2040 and $137.27 by 2050. See the projected annual prices until 2050 of the Proshares Ultrashort Nasdaq Biotechnology 2 X Shares stock below:
- Proshares Ultrashort Nasdaq Biotechnology 2 X Shares (BIS) is expected to reach an average price of $12.59 in 2035, with a high prediction of $12.00 and a low estimate of $12.02. This indicates an $-20.45% rise from the last recorded price of $15.83.
- Proshares Ultrashort Nasdaq Biotechnology 2 X Shares (BIS) stock is projected to chart a bullish course in 2040, with an average price target of $49.60, representing an $213.34% surge from its current level. The forecast ranges from a conservative $50.36 to a sky-high $50.36.
- Our analysts predict Proshares Ultrashort Nasdaq Biotechnology 2 X Shares (BIS) to jump 448.09% by 2045, soaring from $87.78 to an average price of $86.76, potentially reaching $89.07. While $87.78 is the low estimate, the potential upside is significant.
- Proshares Ultrashort Nasdaq Biotechnology 2 X Shares (BIS) stock is expected to climb by 2050, reaching an average of $138.42, a $774.44% jump from its current level. However, a wide range of estimates exists, with high and low targets of $137.27 and $136.63, respectively, highlighting the market's uncertainty.
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Stock (BIS) Year by Year Forecast
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Stock (BIS) Price Forecast for 2025
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Stock (BIS) is expected to reach an average price of $15.02 in 2025, with a high prediction of $30.04 and a low estimate of $0.00793. This indicates an -5.09% fall from the last recorded price of $15.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $4.8781 | $0.00793 | $5.3337 | -69.18% |
| February, 2025 | $9.9444 | $0.939 | $10.78 | -37.18% |
| March, 2025 | $11.72 | $0.5724 | $13.60 | -25.99% |
| April, 2025 | $8.3085 | $1.3378 | $30.04 | -47.51% |
| May, 2025 | $8.7608 | $0.5938 | $13.13 | -44.66% |
| June, 2025 | $12.39 | $6.3155 | $9.5901 | -21.73% |
| July, 2025 | $15.32 | $13.34 | $11.81 | -3.24% |
| August, 2025 | $15.47 | $14.83 | $15.15 | -2.30% |
| September, 2025 | $14.14 | $15.30 | $13.74 | -10.71% |
| October, 2025 | $10.54 | $12.69 | $12.32 | -33.41% |
| November, 2025 | $13.58 | $11.13 | $12.68 | -14.21% |
| December, 2025 | $11.21 | $13.79 | $14.80 | -29.20% |
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Stock (BIS) Price Forecast for 2026
The predicted value for Proshares Ultrashort Nasdaq Biotechnology 2 X Shares (BIS) in 2026 is set at an average of $19.67. Estimates vary from a peak of $22.94 to a trough of $16.41, indicating an +24.28% surge from the present price of $15.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $16.74 | $16.41 | $14.65 | +5.73% |
| February, 2026 | $20.45 | $17.37 | $19.38 | +29.16% |
| March, 2026 | $21.67 | $20.66 | $20.14 | +36.87% |
| April, 2026 | $22.35 | $22.68 | $22.94 | +41.20% |
| May, 2026 | $19.68 | $19.86 | $19.24 | +24.33% |
| June, 2026 | $17.35 | $18.35 | $18.24 | +9.61% |
| July, 2026 | $17.29 | $17.40 | $18.56 | +9.24% |
| August, 2026 | $20.21 | $18.11 | $17.87 | +27.65% |
| September, 2026 | $19.76 | $20.19 | $20.04 | +24.85% |
| October, 2026 | $20.96 | $19.72 | $19.41 | +32.42% |
| November, 2026 | $20.70 | $20.62 | $20.40 | +30.78% |
| December, 2026 | $18.47 | $19.74 | $20.67 | +16.71% |
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Stock (BIS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Proshares Ultrashort Nasdaq Biotechnology 2 X Shares (BIS) is $8.514, with a high forecast of $16.91 and a low forecast of $0.1178. This indicates an -46.22% decrease from the last price of $15.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $16.94 | $17.08 | $16.91 | +7.00% |
| February, 2027 | $15.74 | $15.96 | $16.58 | -0.59% |
| March, 2027 | $15.23 | $14.82 | $14.68 | -3.77% |
| April, 2027 | $11.05 | $12.38 | $14.59 | -30.18% |
| May, 2027 | $7.5826 | $8.0579 | $7.1029 | -52.10% |
| June, 2027 | $4.4972 | $6.0819 | $7.3539 | -71.59% |
| July, 2027 | $8.1285 | $5.9665 | $7.3312 | -48.65% |
| August, 2027 | $5.3678 | $8.2278 | $8.5031 | -66.09% |
| September, 2027 | $3.6944 | $0.7136 | $4.4003 | -76.66% |
| October, 2027 | $0.6563 | $0.1178 | $4.3163 | -95.85% |
| November, 2027 | $6.758 | $4.1557 | $3.578 | -57.31% |
| December, 2027 | $8.1996 | $5.475 | $7.2796 | -48.20% |
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Stock (BIS) Price Forecast for 2028
In 2028, Proshares Ultrashort Nasdaq Biotechnology 2 X Shares (BIS) is projected to reach an average price of $4.3797, with a high projection of $7.5689 and a low estimate of $1.1905. This indicates an -72.33% fall from the last price of $15.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.0589 | $4.8116 | $6.3949 | -74.36% |
| February, 2028 | $2.6882 | $3.9082 | $4.3436 | -83.02% |
| March, 2028 | $6.3048 | $4.8429 | $6.3048 | -60.17% |
| April, 2028 | $7.1841 | $7.2727 | $6.7169 | -54.62% |
| May, 2028 | $6.3607 | $7.1957 | $7.5689 | -59.82% |
| June, 2028 | $6.83 | $6.368 | $6.431 | -56.85% |
| July, 2028 | $5.3293 | $6.3093 | $6.7474 | -66.33% |
| August, 2028 | $1.296 | $3.6863 | $4.9567 | -91.81% |
| September, 2028 | $3.9553 | $2.8506 | $3.1163 | -75.01% |
| October, 2028 | $3.9146 | $4.0746 | $3.8609 | -75.27% |
| November, 2028 | $2.1812 | $1.7638 | $3.0919 | -86.22% |
| December, 2028 | $0.8399 | $1.1905 | $2.0159 | -94.69% |
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Stock (BIS) Price Forecast for 2029
The 2029 price forecast for Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Stock (BIS) is $17.47 on average, with a high prediction of $34.90 and a low estimate of $0.0375. This represents an +10.35% increase from the previous price of $15.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.5571 | $0.5878 | $0.8324 | -96.48% |
| February, 2029 | $0.5136 | $0.0436 | $1.1509 | -96.76% |
| March, 2029 | $1.5043 | $0.0663 | $1.5043 | -90.50% |
| April, 2029 | $3.345 | $1.617 | $4.3823 | -78.87% |
| May, 2029 | $6.7884 | $3.1027 | $7.683 | -57.12% |
| June, 2029 | $4.7391 | $4.7391 | $7.651 | -70.06% |
| July, 2029 | $0.6698 | $0.0798 | $4.8512 | -95.77% |
| August, 2029 | $1.3017 | $0.0375 | $1.3332 | -91.78% |
| September, 2029 | $1.0739 | $0.9459 | $2.5612 | -93.22% |
| October, 2029 | $2.5173 | $0.3966 | $3.0273 | -84.10% |
| November, 2029 | $6.063 | $2.0499 | $6.268 | -61.70% |
| December, 2029 | $37.10 | $4.416 | $34.90 | +134.35% |
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Stock (BIS) Price Forecast for 2030
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Stock (BIS) is expected to reach an average price of $38.12 in 2030, with a high forecast of $49.06 and a low forecast of $27.18. This signifies an +140.81% surge from the last price of $15.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $34.24 | $35.35 | $33.09 | +116.31% |
| February, 2030 | $37.25 | $42.10 | $41.89 | +135.30% |
| March, 2030 | $35.59 | $36.92 | $36.20 | +124.80% |
| April, 2030 | $31.57 | $34.09 | $31.54 | +99.40% |
| May, 2030 | $26.38 | $27.18 | $32.07 | +66.63% |
| June, 2030 | $34.04 | $27.49 | $29.76 | +115.01% |
| July, 2030 | $44.41 | $37.15 | $39.25 | +180.54% |
| August, 2030 | $49.83 | $48.36 | $47.99 | +214.77% |
| September, 2030 | $47.62 | $48.73 | $49.06 | +200.82% |
| October, 2030 | $48.38 | $44.51 | $47.38 | +205.63% |
| November, 2030 | $28.43 | $41.40 | $47.10 | +79.62% |
| December, 2030 | $39.14 | $37.07 | $39.06 | +147.24% |
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):